Pettiti Gianluca's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Nov 12, 2025
- Accession no.
- 0000097745-25-000163
- Filed
- Nov 12, 2025
- Trade date
- Nov 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.73M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pettiti GianlucaCIK 0001844600 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Common Stock | MOption exerciseAcquired | +725 | $253.99 | +$184,142.75 | 21,877.22 | Direct | |
| Nov 10, 2025 | Common Stock | SSaleDisposed | −725 | $580.00 | −$420,500 | 21,152.22 | Direct | |
| Nov 10, 2025 | Common Stock | MOption exerciseAcquired | +2,250 | $294.02 | +$661,545 | 23,402.22 | Direct | |
| Nov 10, 2025 | Common Stock | SSaleDisposed | −2,250 | $580.00 | −$1,305,000 | 21,152.22 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Common Stock | MOption exerciseDisposed | −725 | $0.00 | $0 | 0 | Direct | |
| Nov 10, 2025 | Common Stock | MOption exerciseDisposed | −2,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.